Results 161 to 170 of about 45,700 (265)
Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo‐controlled, crossover trial
European Journal of Heart Failure, EarlyView.Abstract Aims
Heart failure with preserved ejection fraction (HFpEF) is a major healthcare burden with limited treatment options. Geranylgeranylacetone (GGA) has been shown to improve myocardial compliance and endothelial function in preclinical models.Soufiane Nassiri, Geert H.D. Voordes, Loek van Heerebeek, Daniël H. van Raalte, Marianne C. Verhaar, Daan J. Touw, Merle M. Krebber, Dirk J. Duncker, Etto C. Eringa, M. Louis Handoko, Adriaan A. Voors, on behalf of the RECONNEXT Consortium +11 morewiley +1 more sourceLiver stiffness measurement for non‐invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot study
European Journal of Heart Failure, EarlyView.Liver stiffness measurement for central venous pressure assessment. AUC, area under the curve; BMI, body mass index; CI, confidence interval; CVP, central venous pressure; HF, heart failure; LSM, liver stiffness measurement; LVEF, left ventricular ejection fraction. Abstract Aims
Central venous pressure (CVP) is an important variable in assessing heart Nicolas Girerd, Jan Biegus, Adam Janas, Piotr Buszman, Marcin Suska, Ovidiu Chioncel, Julie Foucquier, Anne Llorca, Laura Cantu Sanchez, Marat Fudim, Kevin Damman, Maria Rosa Costanzo, Beth Davison, Gad Cotter, Laurent Sandrin, Victor de Lédinghen, Alexandre Mebazaa +16 morewiley +1 more sourceCardiovascular magnetic resonance‐estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR‐DM‐HF)
European Journal of Heart Failure, EarlyView.Joanna Osmanska, Kieran F. Docherty, Colin Berry, Pardeep S. Jhund, Kenneth Mangion, Patrick B. Mark, John J.V. McMurray, Giles Roditi, Naveed Sattar, Mark C. Petrie, Ross T. Campbell, Matthew M.Y. Lee +11 morewiley +1 more sourcePrognostic value of NT‐proBNP in patients with primary mitral regurgitation undergoing transcatheter edge‐to‐edge repair
European Journal of Heart Failure, EarlyView.In the PRIME‐MR study, patients with higher N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) tertiles more frequently reached death or heart failure hospitalization (HFH) within 3 years. Log‐transformed NT‐proBNP levels independently predicted the primary endpoint (adjusted hazard ratio 1.17, 95% confidence interval 1.07–1.28; p < 0.001).Philipp von Stein, Jessica Weimann, Roman Pfister, Sebastian Ludwig, Benedikt Koell, Erwan Donal, Dhairya Patel, Lukas Stolz, Tetsu Tanaka, Andrea Scotti, Teresa Trenkwalder, Felix Rudolph, Daryoush Samim, Cristina Giannini, Julien Dreyfus, Jean‐Michel Paradis, Marianna Adamo, Nicole Karam, Yohann Bohbot, Anne Bernard, Bruno Melica, Angelo Quagliana, Yoan Lavie Badie, Mirjam Kessler, Omar Chehab, Simon Redwood, Edith Lubos, Lars Sondergaard, Marco Metra, Chiara Primerano, Fabien Praz, Muhammed Gerçek, Erion Xhepa, Georg Nickenig, Azeem Latib, Niklas Schofer, Raj Makkar, Juan F. Granada, Thomas Modine, Jörg Hausleiter, Augustin Coisne, Daniel Kalbacher, Christos Iliadis, on behalf of the PRIME‐MR Investigators, Paul Achouh, David Attias, Stephan Baldus, Alain Berrebi, Guillaume Bonnet, Laura Granada, Frederic Bouisset, Corentin Bourg, Thierry Bourguignon, Diogo Ferreira, Stéphane Lafitte, Thibault Lhermusier, Guillaume L'official, Mohammed Nejjari, Edoardo Pancaldi, Lydia X. Plewe, Tobias Rheude, Natacha Rousse, Volker Rudolph, Dan Rusinaru, Christophe Saint‐Etienne, Francisco Sampaio, Jury Schewel, Arnaud Sudre, Christophe Tribouilloy, Marcel Weber, Stephan Windecker +70 morewiley +1 more sourceA simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides
European Journal of Heart Failure, EarlyView.Jerremy Weerts, Arantxa Barandiarán Aizpurua, Ravi B. Patel, Arno A. van de Bovenkamp, Hesam Amin, Sandra Sanders‐van Wijk, Sanne G.J. Mourmans, Anouk Achten, M. Louis Handoko, Antoni Bayés‐Genís, Hans‐Peter Brunner‐La Rocca, Sanjiv J. Shah, Christian Knackstedt, Vanessa P.M. van Empel +13 morewiley +1 more sourceSex‐based differences in heart failure management and outcomes: Insights from the French‐DataHF cohort
European Journal of Heart Failure, EarlyView.Sex differences in heart failure (HF) management and outcomes in the French‐DataHF cohort. CI, confidence interval; HFH, heart failure hospitalization; HR, hazard ratio; IPW, inverse probability weighting; KM, Kaplan–Meier; LD, loop diuretic; RAS, renin–angiotensin system; RASi, renin–angiotensin system inhibitor.Guillaume Baudry, Ouarda Pereira, François Roubille, Marc Villaceque, Thibaud Damy, Kevin Duarte, Philippe Tangre, Nicolas Girerd +7 morewiley +1 more sourceSafety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study [PDF]
, 2019 Andrew K. Whittaker, Anna Christine Drachmann Kragh, Judith Hartleib‐Geschwindner, Muna Albayaty, Anna Backlund, Peter J. Greasley, Maria Heijer, Michael Kjær, Pablo Forte, Robert J. Unwin, Linda Wernevik, Hans Ericsson +11 moreopenalex +1 more source
